Researchers at University of Tsukuba have identified multiple T-cell subtypes with unique characteristics in follicular ...

We generally favor treating Grade 3b follicular lymphoma as we would diffuse large B-cell lymphoma. How does mutational status impact prognosis?

With follicular lymphoma, you may go through many treatments over many years to keep the disease stable. Here’s a guide to all your options.

Follicular lymphoma can develop into a faster-growing form known as diffuse large B-cell lymphoma. Transformed lymphoma is usually more aggressive and may require more rigorous treatment.

Follicular lymphoma -- typically a slow-growing or indolent form of non-Hodgkin lymphoma that arises from B lymphocytes -- ...

CAR T-cell therapy is one of medicine’s newest weapons against several types of cancer. Learn how this new treatment harnesses the power of your immune system to fight follicular lymphoma.

Patients and Methods Consecutive patients with newly diagnosed, diffuse large B-cell lymphoma (DLBCL) and follicular lymphoma (FL) were enrolled onto a registry and observed prospectively. The impact ...

This marks the second indication for the bispecific CD20-directed CD3 T-cell engager. The agent was first approved in 2023 for relapsed or refractory diffuse large B-cell lymphoma in adults.

It is defined as a lymphoma of follicle center B-cells (centrocytes and centroblasts), which has at least a partially follicular pattern. It is positive for the B-cell markers CD10, CD19, CD20 ...

B cell non-Hodgkin lymphoma is a form of cancer that affects immune cells known as B lymphocytes or B cells. Learn more here.

In Follicular Lymphoma, What are the Risk Factors for Histological Transformation? Utilizing data from the GALLIUM trial, investigators identified several risk factors for histological ...